This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Janssen Biotech, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Pegah Safabakhsh: Innovator in Prostate Neoantigens
Introduction
Pegah Safabakhsh is a prominent inventor based in Philadelphia, PA. She has made significant contributions to the field of biotechnology, particularly in the development of prostate neoantigens. Her work focuses on innovative solutions that have the potential to impact cancer treatment.
Latest Patents
Pegah holds a patent for "Prostate neoantigens and their uses." This patent encompasses a range of elements including polynucleotides encoding prostate neoantigens, vectors, host cells, recombinant virus particles, and vaccines. The patent also covers proteinaceous molecules that bind to the prostate neoantigens, along with methods for making and utilizing these components.
Career Highlights
Pegah is currently employed at Janssen Biotech, Inc., where she continues to advance her research in the field. Her work is characterized by a commitment to innovation and the development of new therapeutic strategies.
Collaborations
Pegah collaborates with notable colleagues such as Kurtis Bachman and Vipul Bhargava, contributing to a dynamic research environment that fosters creativity and scientific advancement.
Conclusion
Pegah Safabakhsh is a trailblazer in the field of prostate neoantigens, with a patent that showcases her innovative spirit and dedication to improving cancer therapies. Her contributions are paving the way for future advancements in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
